MedGenome launches genetic test to diagnose FSHD1
For the first time, Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) test has been launched by MedGenome Laboratory in India.
Stay updated with breaking news from Lab Operations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For the first time, Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) test has been launched by MedGenome Laboratory in India.
Operator: Good day, ladies and gentlemen, and welcome to the NeoGenomics Third Quarter 2022 Earnings Call.
Antimicrobial Resistance (AMR) continues to pose a significant public health problem in terms of mortality and economic loss. The rising AMR is a matter of huge concern that needs to be tactfully handled and health authorities of several countries, including India, have formulated action plans for its containment. Significant efforts by the government, an active involvement of startups and diagnostic players is a good start. The question remains, whether this will be enough. Let's find out.
At the Center for Breakthrough Medicines, Shailah launched their analytical development labs and piloted the rollout of GMP testing.
Toronto, ON (PRWEB) August 03, 2022 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical